- Open Access
A role for DNA-dependent activator of interferon regulatory factor in the recognition of herpes simplex virus type 1 by glial cells
© Furr et al; licensee BioMed Central Ltd. 2011
- Received: 14 April 2011
- Accepted: 12 August 2011
- Published: 12 August 2011
The rapid onset of potentially lethal neuroinflammation is a defining feature of viral encephalitis. Microglia and astrocytes are likely to play a significant role in viral encephalitis pathophysiology as they are ideally positioned to respond to invading central nervous system (CNS) pathogens by producing key inflammatory mediators. Recently, DNA-dependent activator of IFN regulatory factor (DAI) has been reported to function as an intracellular sensor for DNA viruses. To date, the expression and functional role of DAI in the inflammatory responses of resident CNS cells to neurotropic DNA viruses has not been reported.
Expression of DAI and its downstream effector molecules was determined in C57BL/6-derived microglia and astrocytes, either at rest or following exposure to herpes simplex virus type 1 (HSV-1) and/or murine gammaherpesvirus-68 (MHV-68), by immunoblot analysis. In addition, such expression was studied in ex vivo microglia/macrophages and astrocytes from uninfected animals or mice infected with HSV-1. Inflammatory cytokine production by glial cultures following transfection with a DAI specific ligand (B-DNA), or following HSV-1 challenge in the absence or presence of siRNA directed against DAI, was assessed by specific capture ELISA. The production of soluble neurotoxic mediators by HSV-1 infected glia following DAI knockdown was assessed by analysis of the susceptibility of neuron-like cells to conditioned glial media.
We show that isolated microglia and astrocytes constitutively express DAI and its effector molecules, and show that such expression is upregulated following DNA virus challenge. We demonstrate that these resident CNS cells express DAI in situ, and show that its expression is similarly elevated in a murine model of HSV-1 encephalitis. Importantly, we show B-DNA transfection can elicit inflammatory cytokine production by isolated glial cells and DAI knockdown can significantly reduce microglial and astrocyte responses to HSV-1. Finally, we demonstrate that HSV-1 challenged microglia and astrocytes release neurotoxic mediators and show that such production is significantly attenuated following DAI knockdown.
The functional expression of DAI by microglia and astrocytes may represent an important innate immune mechanism underlying the rapid and potentially lethal inflammation associated with neurotropic DNA virus infection.
- DNA-dependent activator of IFN regulatory factor
- innate immunity
- herpes simplex virus-1
The neurotropic DNA virus herpes simplex virus type 1 (HSV-1) is capable of causing severe necrotizing encephalitis and accounts for 95% of all fatal cases of sporadic viral encephalitis . Untreated HSV-1 encephalitis has a 70% mortality rate and patients who receive early treatment have only a 40% chance of recovery without significant neurological deficits. Furthermore, the overall mortality rate of HSV-1 encephalitis in the US remains at 30% despite improvements in diagnosis and therapy . It has recently been shown that HSV-1-mediated cytokine and chemokine production contributes to CNS damage following in vivo infection suggesting that an overzealous host response is a major contributor to the neuropathology associated with acute viral encephalitis [3–7]. However, the mechanisms underlying the onset of such damaging neuroinflammation have not been defined.
The rapid onset of inflammation following CNS infection suggests that resident glial cells play a pivotal role in the initiation and progression of encephalitis. Microglia and astrocytes are resident cells of the CNS cells and are susceptible to HSV-1 infection . Both of these cell types are now recognized to have innate immune functions and respond to invading pathogens by producing soluble mediators that can promote inflammation and leukocyte recruitment across the blood-brain barrier [9–11]. Importantly, microglia have been shown to produce significant levels of the proinflammatory cytokines TNF-α and IL-6 in response to HSV-1 infection . While host immune cells have been shown to recognize HSV-1 or HSV-2 via cell-surface/endosomal pattern recognition receptors including Toll-like receptor (TLR) 2, and TLR9 [13, 14], the means by which resident CNS cells perceive DNA virus infection and initiate inflammatory cytokine production have not been defined.
Recently, the cytosolic protein, DNA-dependent activator of interferon-regulatory factors (DAI; also known as Z-DNA-binding protein 1 (ZBP1)), has been reported to function as an innate sensor of intracellular viral DNA [15–18]. This molecule has been shown to recognize double-stranded DNA in its canonical B helical form (B-DNA) [17, 18] and elicit type-I IFN production in a TANK-binding kinase 1 and interferon regulatory factor 3 dependent, but TLR9-independent, manner [16, 19]. Importantly, this cytosolic sensor has been reported to mediate type I interferon and inflammatory cytokine production by HSV-1-infected murine fibroblasts . To date, DAI expression has not been reported in microglia or astrocytes, and a role for this putative viral sensor in the innate immune responses of resident CNS cells to viral challenge has not been explored. In the present study, we provide the first demonstration of constitutive and inducible expression of DAI and its downstream effector molecules by glial cells both in vitro and in situ. Importantly, we confirm the functional status of DAI in primary microglia and astrocytes and demonstrate that this viral sensor plays a significant role in the inflammatory responses of resident CNS cells to HSV-1 challenge.
Isolation of primary murine microglia and astrocytes
Murine neonatal brain microglia and astrocytes were isolated as described previously [20–22]. Microglia were cultured in RPMI 1640 with 10% FBS and 20% conditioned medium from LADMAC cells (ATCC, CRL-2420) as a source of colony stimulating factor-1 while astrocytes were cultured in RPMI 1640 containing 10% FBS. Cells isolated in this manner were >95% and >97% authentic microglia and astrocytes, respectively, as assessed by their characteristic morphology and by expression of the microglial/macrophage markers CD11b and F4/80 or the astrocyte marker glial fibrillary acidic protein (GFAP) as determined by immunofluorescent microscopy.
Preparation of viral stocks
HSV-1 viral stocks were prepared by infecting monolayer cultures of Vero cells (ATCC; CCL-81) with HSV-1 (MacIntyre strain from a patient with encephalitis; ATCC, VR-539) at a low multiplicity of infection (MOI) of 0.05 plaque-forming units (PFU) per cell and incubated for 48 hours at 34°C in SFM4MegaVir protein-free medium (Thermo Scientific Hyclone, Waltham, MA). Cells were removed with trypsin and pulse sonicated (Vibra Cell; Sonics & Materials Inc., Newtown, CT) to release intact virions. The sonicated material was centrifuged to remove unwanted cellular debris and the viral titers in the cell-free supernatant was quantified using a standard plaque assay of serial dilutions of HSV-1 on Vero cells at 34°C. MHV-68 viral stocks were prepared by infecting monolayer cultures of BHK-21 cells (ATCC, CCL-10) at a low viral MOI of 0.1 PFU per cell. After 24 hour, the cells were removed with trypsin and pulse sonicated to release intact virions. The sonicated material was centrifuged to remove unwanted cellular debris and the supernatant containing virus was aliquoted and stored at -80°C. The medium containing released virus was collected and viral titers were quantified using a standard plaque assay of threefold serial dilutions on NIH-3T3 cells at 34°C.
In vitro infection with HSV-1 and MHV-68
Isolated primary microglia and astrocytes were infected with HSV-1 or MHV-68 at MOIs of 0.01, 0.1, 1, and 10 PFU per cell and the viruses were allowed to adsorb for 1 hour prior to washing to remove nonadherent viral particles. Cultures were maintained for 12 or 24 hours prior to collection of culture supernatants or preparation of whole cell protein isolates.
Western blot analyses for DAI, RIP3, STING, and a HSV-1 gene product
Western blot analyses for the presence of DAI, receptor-interacting protein 3 (RIP3), stimulator of interferon genes (STING), and the HSV-1 gene product glycoprotein G-1 (gG1) in microglia, astrocytes, and whole brain samples were performed as described previously by our laboratory [21, 23, 24]. After incubation with a rabbit polyclonal antibody against DAI (Abcam, Cambridge, MA), RIP3 (Abcam, Cambridge, MA), STING (Abcam, Cambridge, MA) or a mouse monoclonal antibody against gG1 (Abnova, Taipei, Taiwan) for 24 hours at 4°C, blots were washed and incubated in the presence of an horseradish peroxidase (HRP)-conjugated anti-rabbit antibody (Cell Signaling, Danvers, MA) or an HRP-conjugated anti-mouse antibody (Cell Signaling, Danvers, MA), respectively. Bound enzyme was detected with the Super Signal system (Thermo Scientific, Rockford, IL). The expression level of an unidentified non-specific protein present in Coomassie blue stained membranes was determined to confirm equal protein loading in each lane (loading control: lc). Immunoblots shown are representative of at least three separate experiments.
Densitometric analysis of each immunoblot was performed using ImageJ obtained from the NIH Web site http://rsbweb.nih.gov/ij/download.html. Results are presented as fold increases in the number of arbitrary densitometric units, corrected for background intensity and normalized to the expression of the loading control protein, over those in unstimulated cells.
In vivo HSV-1 infection
HSV-1 (MacIntyre strain) was administered to 4-6 week-old female C57BL/6 mice (Jackson Laboratories) via intranasal (i.n.) infection essentially as described by our laboratory with other viral pathogens [23, 25]. Anesthetized animals were untreated or received i.n. HSV-1 administration (1 × 105 -1 × 106 PFU) in PBS (final volume of 20 μl). Animals were euthanized at 4 days post-infection and protein isolates were prepared from whole brain tissue homogenates or glial cells isolated from infected and uninfected animals by flow cytometry as described below. All studies were performed in accordance with relevant federal guidelines and institutional policies regarding the use of animals for research purposes.
Isolation and cytometric analysis of ex vivo CNS cells
Mixed CNS cells were isolated from infected and uninfected animals using a protocol modified from Campanella and coworkers  as previously described . Whole brains were rapidly removed and mechanically disrupted in a glass homogenizer, washed, and resuspended in PBS/30% Percoll (Fluka, Sigma Aldrich, St. Louis, MO) solution. This was overlaid on a gradient containing 37% and 70% Percoll solutions and centrifuged at 600 × G for 20 minutes at room temperature. Glial cells were then collected from the interface and washed with PBS. Microglia/macrophages and astrocytes were isolated from the mixed glial preparation by flow cytometry using an R-phycoerythrin conjugated monoclonal antibody directed against mouse CD11b (BD Biosciences, clone M1-70) and an AlexaFluor488-conjugated monoclonal antibody directed against mouse GFAP (Invitrogen, Eugene, OR, clone 131-17719), respectively. Protein isolates were prepared and analyzed for the presence of DAI, STING, RIP3, and viral gG1 by immunoblot analysis.
In vitro stimulation of microglia and astrocytes with the DAI ligand, B-DNA
Poly(dA:dT) double-stranded B-DNA (InvivoGen, San Diego, CA) was directly introduced into microglia and astrocytes at concentrations of 3 μg/ml and 6 μg/ml using FuGENE HD Transfection Reagent (Promega, Madison, WI) according to the manufacturer's instructions. At 6 and 12 hours following transfection, culture supernatants and whole cell protein isolates were collected for analysis. For comparison purposes, cells were exposed to transfection reagent alone or HSV-1 (MOI of 1 and 10) for 24 hours.
Quantification of IL-6 and TNF-α secretion in glial cell culture supernatants
Specific capture ELISAs were performed to quantify IL-6 and TNF-α as described previously by our laboratory [20–24]. A commercially available ELISA kit was used to measure TNF-α (R&D Systems, Minneapolis, MN) secretion while IL-6 secretion was measured using a rat anti-mouse IL-6 capture antibody (Clone MP5-20F3) and a biotinylated rat anti-mouse IL-6 detection antibody (Clone MP5-C2311) (BD Pharmingen, San Diego, CA).
siRNA-mediated DAI knockdown
Assessment of soluble neurotoxic mediator production by infected microglia and astrocytes
Transfected or untransfected microglia and astrocytes were uninfected or infected with HSV-1 (MOI of 1 PFU per cell) for 1 hour prior to washing to remove non-adherent viral particles. At 24 hours following infection, the conditioned medium was collected and filtered using a 0.1-μm syringe filter (Sterlitech, Kent, WA) to remove residual HSV-1 particles (180 - 200 nm in diameter) prior to addition to resting CATH.a murine neuron-like cell cultures (ATCC #CRL-11179). Our ability to remove all infectious viral particles from the conditioned medium was verified in parallel experiments by demonstrating the exclusion of the smaller vesicular stomatitis virus (0.1-0.4 nm in length) engineered to express green fluorescent protein as described previously [23, 24]. At 4, 8, and 12 hours following filtered conditioned medium addition, the numbers of adherent CATH.a cells were counted in ten microscopy fields and viability was assessed by trypan blue exclusion.
Results of the present studies were tested statistically by one-way ANOVA and Tukey's post hoc test using commercially available software (SAS Institute, Cary, NC). Results were considered statistically significant when a p value of less than 0.05 was obtained.
Primary glial cells express DAI and its associated downstream effector molecules
Finally, to begin to determine whether DAI is functional in glial cells we have investigated whether these cells express RIP3 and STING, two critical downstream effector molecules in DAI signaling [29–31]. As shown in Figure 2C, both microglia and astrocytes constitutively express robust levels of RIP3 and STING. In contrast to DAI expression, STING levels were essentially unaltered following viral challenge (Figure 2C) and while RIP3 expression tended to decrease in microglia following HSV-1 challenge (maximal decrease of 1.5 +/- 0.3 fold; n = 3) and increase in astrocytes (maximal increase of 1.4 +/- 0.2 fold, n = 3) such effects were not statistically significant.
In vivo HSV-1 infection induces DAI expression by microglia/macrophages and astrocytes
Furthermore, we assessed glial DAI expression following in vivo HSV-1 infection. To confirm that i.n. HSV-1 administration infects glial cells in situ we determined the expression of HSV-1 glycoprotein G1 (gG1) in microglia and astrocytes isolated from infected and sham-infected mice. As shown in Figure 3C, this HSV-1 gene product was absent in cells derived from sham infected mice but was readily detectable in glial cells isolated from the brains of infected animals with astrocytes exhibiting higher levels than microglia/macrophages. Importantly, in vivo HSV-1 challenge elicited marked increases in DAI expression in both microglia/macrophages (24.8 fold) and astrocytes (8.5 fold) isolated from the brains of infected animals (Figure 3B) in the absence of significant increases in levels of this viral sensor in total brain protein isolates (Figure 3A). Finally, we assessed the expression of the DAI downstream effector molecules RIP3 and STING in glia isolated from HSV-1 infected and sham infected mice. As shown in Figure 3D, microglia/macrophages and astrocytes isolated from uninfected brain tissue showed detectable levels of RIP3 and STING. Consistent with our in vitro findings, in vivo HSV-1 infection failed to elicit significant changes in RIP3 expression by either cell type. Interestingly, and in contrast to our studies in cultured cells, STING expression was significantly elevated in both microglia/macrophages and astrocytes following in vivo HSV-1 infection (Figure 3D). While it is likely that STING expression is regulated in vivo by as yet unidentified factors, it must be noted that resting cultured glial cells express high levels of this molecule (Figure 2C), perhaps due to in vitro culture conditions and/or adherence to plastic, and so further increases in STING expression may not be possible in such cells.
B-DNA induces inflammatory mediator production by primary murine microglia and astrocytes
DAI knockdown attenuates HSV-induced inflammatory cytokine production by primary glia
DAI is required for virally-induced production of neurotoxic mediators by microglia and astrocytes
Several members of the herpesvirus family including human herpesvirus 6, HSV-1, and HSV-2 can elicit damaging CNS inflammation [2, 32]. Acute HSV -1 infection or the reactivation of latent virus in the trigeminal ganglion can lead to the development of severe encephalitis that is associated with a high degree of morbidity and mortality. While acyclovir is currently employed in the treatment of HSV encephalitis, drug-resistant strains of HSV-1 are beginning to emerge [33, 34]. Furthermore, despite improvements in diagnosis such infections are associated with a 30% mortality rate and 62% of survivors recover with severe neurological deficits [33, 35, 36]. The treatment of HSV-1 associated encephalitis is especially challenging due to the rapid onset of disease and development of irreversible neurological damage in otherwise healthy individuals. These characteristics suggest that the innate immune responses of resident CNS cells play a pivotal role in disease progression, a notion that is supported by the ability of human microglia to produce key inflammatory mediators in response to in vitro HSV challenge or following in vivo infection [37–40]. However, much of our current understanding of HSV-1 encephalitis pathogenesis comes from rodent models in which intranasal HSV-1 administration results in an acute necrotizing encephalitis that closely resembles human disease [41–45]. In these models, HSV-1 infects both neurons and glial cells and elicits inflammatory mediator production that precedes leukocyte infiltration into the CNS [41, 46]. Such findings are consistent with the recognized ability of other viral pathogens to induce inflammatory cytokine production by microglia  and the susceptibility and responsiveness of astrocytes to productive HSV-1 infection [8, 48]. However, the mechanisms by which resident CNS cells recognize DNA viral pathogens such as HSV-1 have not been fully defined.
We and others have demonstrated that microglia and astrocytes express an array of cell surface and endosomal innate pattern recognition receptors, including TLR2 [9, 21], TLR3 [49, 50], TLR7 , and TLR9 , that are capable of recognizing viral motifs . Importantly, each of these cell surface sensors has been implicated in the perception of HSV by a variety of cell types [13, 14, 51, 52]. However, it is becoming increasingly apparent that cells, including glia, possess intracellular sensors that can detect compromise of the cytosolic compartment. We have recently demonstrated that murine and human glial cells functionally express retinoic acid-inducible gene I (RIG-I) and melanoma differentiation-associated antigen 5 (MDA5) [23, 24], two members of the RIG-I-like family of helicases that have been shown to function as intracellular pattern recognition receptors for replicative viral RNA motifs [51, 53]. It is possible that such receptors may also indirectly serve as sensors for viral and/or bacterial DNA via the actions of RNA polymerase III  although a role for this pathway in HSV recognition by immune cells remains controversial . Interestingly, a number of cytosolic proteins including DAI have been described that can directly mediate cellular responses to dsDNA [17, 18, 53]. It has therefore been suggested that such sensors could play a critical role in the perception of viral DNA and this notion has been supported by the report that DAI mediates immune molecule production by HSV-1-infected murine fibroblasts .
In the present study, we provide the first evidence that glial cells express DAI. Resting cultures of primary microglia expressed low levels of this intracellular viral sensor, a finding that is consistent with the very low DAI expression observed in ex vivo microglia. In contrast, cultured astrocytes constitutively expressed robust levels of this molecule, although it should be noted that this might be attributable, in part, to our in vitro culture conditions, as astrocytes acutely isolated from uninfected mice expressed somewhat lower DAI levels. Importantly, DAI expression was significantly elevated in microglia and astrocytes following either in vitro or in vivo HSV-1 challenge. Such upregulation was not specific to this neurotropic alphaherpesvirus as the leukotropic gammaherpesvirus, MHV-68, was also capable of elevating DAI expression by both cell types. As such, it is possible that glial perception of DNA viruses via this sensor could promote further DAI expression in a feed-forward manner. The constitutive expression of this viral sensor by glial cells and its upregulation following viral challenge provide circumstantial evidence of a role for DAI in glial responses to DNA viral pathogens. This notion is further supported by the robust constitutive expression by microglia and astrocytes of IPS-1 , STING, and RIP3, reportedly critical downstream effector molecules for DAI [29–31]. Importantly, we have confirmed that DAI is functional in primary murine glia by showing that cytoplasmic administration of the DAI ligand, B-DNA, is a potent stimulus for the production of key inflammatory mediators by both microglia and astrocytes. Finally, we have demonstrated a major role for this intracellular viral sensor in the immune responses of primary murine glia to a clinically relevant neurotropic DNA virus by demonstrating that DAI knockdown significantly and specifically inhibits HSV-1-induced inflammatory cytokine production by these cells.
Host responses to viral CNS infections are increasingly recognized to play a major role in disease pathology and the neuroinflammation elicited by HSV-1 has been suggested to underlie the neurological damage associated with infection [3–7]. However, it not clear whether this inflammatory damage is mediated primarily by infiltrating leukocytes or by the responses of the resident cells of the CNS themselves. In support of the latter possibility, activated glial cells are known to be capable of producing toxic mediators that can cause widespread CNS damage . Furthermore, the rapidity with which HSV-1 travels from the initial site of infection to the brain all but assures escape from recognition by adaptive immune cells. Based on these observations, it appears likely that the production of cytotoxic substances by HSV-1 challenged glial cells could play a significant role in neuronal cell dysfunction and/or loss and contribute to the neuropathology associated with HSV-1 encephalitis. In the present study, we have demonstrated that soluble factor(s) released by HSV-infected microglia and astrocytes elicit neuronal cell damage/death and that the production of this factor(s) is dependent, at least in part, on the expression of DAI. While the identification of this/these neurotoxic factor(s) is ongoing in our laboratory, we have shown that TNF-a is released by HSV-1 infected glia (Figure 4) and this cytokine can elicit neuronal cell death (Figure 6). In contrast, we have found that another likely candidate, nitric oxide, is not released by either microglia or astrocytes following HSV-1 infection as assessed by culture medium nitrite content (data not shown) and is therefore unlikely to be a contributing factor to neuronal cell death. Irrespective of the mediator(s) involved, our findings directly implicate DAI in the initiation of inflammatory immune responses by glial cells and suggest a novel mechanism underlying the neuropathology associated with acute DNA viral infections of the CNS.
This work was supported by grant NS050325 to IM from the National Institutes of Health.
- Xu F, Sternberg MR, Kottiri BJ, McQuillan GM, Lee FK, Nahmias AJ, Berman SM, Markowitz LE: Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA. 2006, 296: 964-973. 10.1001/jama.296.8.964.View ArticlePubMedGoogle Scholar
- Baringer JR: Herpes Simplex Infections of the Nervous System. Neurol Clin. 2008, 26: 657-674. 10.1016/j.ncl.2008.03.005.View ArticlePubMedGoogle Scholar
- Nakajima H, Kobayashi M, Pollard RB, Suzuki F: Monocyte chemoattractant protein-1 enhances HSV-induced encephalomyelitis by stimulating Th2 responses. J Leukoc Biol. 2001, 70: 374-380.PubMedGoogle Scholar
- Rosler A, Pohl M, Braune HJ, Oertel WH, Gemsa D, Sprenger H: Time course of chemokines in the cerebrospinal fluid and serum during herpes simplex type 1 encephalitis. J Neurol Sci. 1998, 157: 82-89. 10.1016/S0022-510X(98)00061-6.View ArticlePubMedGoogle Scholar
- Wildemann B, Ehrhart K, Storch-Hagenlocher B, Meyding-Lamade U, Steinvorth S, Hacke W, Haas J: Quantitation of herpes simplex virus type 1 DNA in cells of cerebrospinal fluid of patients with herpes simplex virus encephalitis. Neurology. 1997, 48: 1341-1346.View ArticlePubMedGoogle Scholar
- Trifilo MJ, Lane TE: Adenovirus-mediated expression of CXCL10 in the central nervous system results in T-cell recruitment and limited neuropathology. J Neurovirol. 2003, 9: 315-324.View ArticlePubMedGoogle Scholar
- Conrady CD, Drevets DA, Carr DJ: Herpes simplex type I (HSV-1) infection of the nervous system: is an immune response a good thing?. J Neuroimmunol. 2010, 220: 1-9. 10.1016/j.jneuroim.2009.09.013.PubMed CentralView ArticlePubMedGoogle Scholar
- Aravalli RN, Hu S, Rowen TN, Gekker G, Lokensgard JR: Differential apoptotic signaling in primary glial cells infected with herpes simplex virus 1. J Neurovirol. 2006, 12: 501-510. 10.1080/13550280601064921.View ArticlePubMedGoogle Scholar
- Konat GW, Kielian T, Marriott I: The role of Toll-like receptors in CNS response to microbial challenge. J Neurochem. 2006, 99: 1-12.PubMed CentralView ArticlePubMedGoogle Scholar
- Carpentier PA, Duncan DS, Miller SD: Glial toll-like receptor signaling in central nervous system infection and autoimmunity. Brain Behav Immun. 2008, 22: 140-147. 10.1016/j.bbi.2007.08.011.PubMed CentralView ArticlePubMedGoogle Scholar
- Falsig J, van Beek J, Hermann C, Leist M: Molecular basis for detection of invading pathogens in the brain. J Neurosci Res. 2008, 86: 1434-1447. 10.1002/jnr.21590.View ArticlePubMedGoogle Scholar
- Lokensgard JR, Hu S, Sheng W, vanOijen M, Cox D, Cheeran MC, Peterson PK: Robust expression of TNF-alpha, IL-1beta, RANTES, and IP-10 by human microglial cells during nonproductive infection with herpes simplex virus. J Neurovirol. 2001, 7: 208-219. 10.1080/13550280152403254.View ArticlePubMedGoogle Scholar
- Lund J, Sato A, Akira S, Medzhitov R, Iwasaki A: Toll-like receptor 9-mediated recognition of herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med. 2003, 198: 513-520. 10.1084/jem.20030162.PubMed CentralView ArticlePubMedGoogle Scholar
- Kurt-Jones E, Mandell L, Cerny A, Chan M, Zhou S, Reed G, Bronson R, Arnold MM, Knipe DM, Finberg RW: Neonatal herpes simplex infection: Herpes simplex virus I interaction with TLR2 contributes to lethal encephalitis. Proc Natl Acad Sci. 2004, 101: 1315-1320. 10.1073/pnas.0308057100.PubMed CentralView ArticlePubMedGoogle Scholar
- Fu Y, Comella N, Tognazzi K, Brown LF, Dvorak HF, Kocher O: Cloning of DLM-1, a novel gene that is up-regulated in activated macrophages, using RNA differential display. Gene. 1999, 240: 157-163. 10.1016/S0378-1119(99)00419-9.View ArticlePubMedGoogle Scholar
- Ishii KJ, Coban C, Kato H, Takahashi K, Torii Y, Takeshita F: A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat Immunol. 2006, 7: 40-48. 10.1038/ni1282.View ArticlePubMedGoogle Scholar
- Takaoka A, Wang Z, Choi M, Yanai H, Negishi H, Ban T, Lu Y, Miyagishi M, Kodama T, Hondra K, Ohba Y, Taniguchi T: DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature. 2007, 448: 501-506. 10.1038/nature06013.View ArticlePubMedGoogle Scholar
- Wang Z, Choi MK, Ban T, Yanai H, Negishi H, Lu Y, Tamura T, Takaoka A, Nishikura K, Taniguchi T: Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules. Proc Natl Acad Sci. 2008, 105: 5477-5482. 10.1073/pnas.0801295105.PubMed CentralView ArticlePubMedGoogle Scholar
- Stetson DB, Medzhitov R: Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity. 2006, 24: 93-103. 10.1016/j.immuni.2005.12.003.View ArticlePubMedGoogle Scholar
- Rasley A, Anguita J, Marriott I: Borrelia burgdorferi induces inflammatory mediator production by murine microglia. J Neuroimmunol. 2002, 130: 22-31. 10.1016/S0165-5728(02)00187-X.View ArticlePubMedGoogle Scholar
- Bowman CC, Rasley A, Tranguch SL, Marriott I: Cultured astrocytes express toll-like receptors for bacterial products. Glia. 2003, 43: 281-291. 10.1002/glia.10256.View ArticlePubMedGoogle Scholar
- Rasley A, Bost KL, Marriott I: Murine gammaherpesvirus-68 elicits robust levels of interleukin-12 p40, but not interleukin-12 p70 production, by murine microglia and astrocytes. J Neurovirol. 2004, 10: 171-180. 10.1080/13550280490444119.View ArticlePubMedGoogle Scholar
- Furr SR, Chauhan VS, Sterka D, Grdzelishvili VZ, Marriott I: Characterization of retinoic acid-inducible gene-I expression in primary murine glia following exposure to vesicular stomatitis virus. J Neurovirol. 2008, 7: 1-11.Google Scholar
- Furr SR, Moedyck-Schauwecker M, Grdzelishvili VZ, Marriott I: RIG-I mediates nonsegmented single-stranded RNA virus-induced inflammatory immune responses of primary human astrocytes. Glia. 2010, 58: 1620-1629.PubMed CentralPubMedGoogle Scholar
- Gasper-Smith N, Marriott I, Bost KL: Murine gamma-herpesvirus 68 limits naturally occurring CD4+CD25+T regulatory cell activity following infection. J Immunol. 2006, 177: 4670-4678.View ArticlePubMedGoogle Scholar
- Campanella M, Sciorati C, Tarozzo G, Beltramo M: Flow cytometric analysis of inflammatory cells in ischemic rat brain. Stroke. 2003, 33: 586-592.View ArticleGoogle Scholar
- Chauhan VS, Sterka DG, Gray DL, Bost KL, Marriott I: Neurogenic exacerbation of microglial and astrocyte responses to Neisseria meningitidis and Borrelia burgdorferi. J Immunol. 2008, 180: 8241-8249.PubMed CentralView ArticlePubMedGoogle Scholar
- Flano E, Woodland DL, Blackman MA: A mouse model for infectious mononucleosis. Immunol Res. 2002, 25: 201-217. 10.1385/IR:25:3:201.View ArticlePubMedGoogle Scholar
- Rebsamen M, Heinz LX, Meylan E, Michallet MC, Schroder K, Hofmann K, Vazquez J, Benedict CA, Tschopp J: DAI/ZBP1 recruits RIP1 and RIP3 through RIP homotypic interaction motifs to activate NF-kappaB. EMBO. 2009, 10: 916-922. 10.1038/embor.2009.109.View ArticleGoogle Scholar
- Ishikawa H, Barber GN: STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature. 2008, 455: 674-678. 10.1038/nature07317. Erratum in: Nature, 2008 456:274PubMed CentralView ArticlePubMedGoogle Scholar
- Ishikawa H, Ma Z, Barber GN: STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature. 2009, 461: 788-792. 10.1038/nature08476.PubMed CentralView ArticlePubMedGoogle Scholar
- Isaacson E, Glaser CA, Forghani B, Amad Z, Wallace M, Armstrong RW, Exner MM, Schmid S: Evidence of human herpesvirus 6 infection in 4 immunocompetent patients with encephalitis. Clin Infect Dis. 2005, 40: 890-893. 10.1086/427944.View ArticlePubMedGoogle Scholar
- Whitley RJ, Alford CA, Hirsch MS, Schooley RT, Luby JP, Aoki FY, Hanley D, Nahmias AJ, Soong SJ: Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med. 1986, 314: 144-149. 10.1056/NEJM198601163140303.View ArticlePubMedGoogle Scholar
- Kimberlin DW: Management of HSV encephalitis in adults and neonates: diagnosis, prognosis and treatment. Herpes. 2007, 14: 11-16.PubMedGoogle Scholar
- Raschilas F, Wolff M, Delatour F, Chaffaut C, De Broucker T, Chevret S, Lebon P, Canton P, Rozenberg F: Outcome of and prognostic factors for herpes simplex encephalitis in adult patients: results of a multicenter study. Clin Infect Dis. 2002, 35: 254-260. 10.1086/341405.View ArticlePubMedGoogle Scholar
- Hjalmarsson A, Blomqvist P, Sköldenberg B: Herpes simplex encephalitis in Sweden, 1990-2001: incidence, morbidity, and mortality. Clin Infect Dis. 2007, 45: 875-880. 10.1086/521262.View ArticlePubMedGoogle Scholar
- Hu S, Sheng W, vanOijen M, Cox D, Cheeran MC, Peterson PK: Robust expression of TNF-alpha, IL-1beta, RANTES, and IP-10 by human microglial cells during nonproductive infection with herpes simplex virus. J Neurovirol. 2001, 7: 208-219. 10.1080/13550280152403254.View ArticlePubMedGoogle Scholar
- Marques CP, Hu S, Sheng W, Cheeran MC, Cox D, Lokensgard JR: Interleukin-10 attenuates production of HSV-induced inflammatory mediators by human microglia. Glia. 2004, 47: 358-366. 10.1002/glia.20045.View ArticlePubMedGoogle Scholar
- Marques CP, Cheeran MC, Palmquist JM, Hu S, Urban SL, Lokensgard JR: Prolonged microglial cell activation and lymphocyte infiltration following experimental herpes encephalitis. J Immunol. 2008, 181: 6417-6426.PubMed CentralView ArticlePubMedGoogle Scholar
- Marques CP, Hu S, Sheng W, Lokensgard JR: Microglial cells initiate vigorous yet non-protective immune responses during HSV-1 brain infection. Virus Research. 121: 1-10.Google Scholar
- Mori I, Goshima F, Ito H, Koide N, Yoshida T, Yokochi T, Kimura Y, Nishiyama Y: The vomeronasal chemosensory system as a route of neuroinvasion by herpes simplex virus. Virology. 2005, 334: 51-58. 10.1016/j.virol.2005.01.023.View ArticlePubMedGoogle Scholar
- Ikemoto K, Pollard R, Fukumoto T, Morimatsu M, Suzuki F: Small amounts of exogenous IL-4 increase the severity of encephalitis induced in mice by the intranasal infection of herpes simplex virus type 1. J Immunol. 1995, 155: 1326-1333.PubMedGoogle Scholar
- Esiri MM, Drummond CWE, Morris CS: Macrophages and microglia in HSV-1 infected mouse brain. J Neuroimmunol. 1995, 62: 201-205. 10.1016/0165-5728(95)00123-8.View ArticlePubMedGoogle Scholar
- Mansur DS, Kroon EG, Nogueira ML, Arantes RME, Rodrigues SCO, Akira S, Gazzinelli RT, Campos MA: Lethal encephalitis in myeloid differentiation factor 88-deficient mice infected with herpes simplex virus 1. Am J Pathol. 2005, 166: 1419-1426. 10.1016/S0002-9440(10)62359-0.PubMed CentralView ArticlePubMedGoogle Scholar
- Nair A, Hunzeker J, Bonneau RH: Modulation of microglia and CD8+ T cell activation during the development of stress-induced herpes simplex virus type-1 encephalitis. Brain Behav Immun. 2007, 21: 791-806. 10.1016/j.bbi.2007.01.005.View ArticlePubMedGoogle Scholar
- Beers DR, Henkel JS, Kesner RP, Stroop WG: Spatial recognition memory deficits without notable CNS pathology in rats following herpes simplex encephalitis. J Neurol Sci. 1995, 131: 119-127. 10.1016/0022-510X(95)00099-N.View ArticlePubMedGoogle Scholar
- Mariani MM, Kielian T: Microglia in infectious diseases of the central nervous system. J Neuroimmune Pharmacol. 2009, 4: 448-461. 10.1007/s11481-009-9170-6.PubMed CentralView ArticlePubMedGoogle Scholar
- Dix RD, Hurst LI, Keane RW: Herpes simplex virus type 1 infection of mouse astrocytes treated with basic fibroblast growth factor. Journal of General Virology. 1992, 73: 1845-1848. 10.1099/0022-1317-73-7-1845.View ArticlePubMedGoogle Scholar
- Bsibsi M, Persoon-Deen C, Verwer RW, Meeuwsen S, Ravid R, Van Noort JM: Toll-like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators. Glia. 2006, 53: 688-695. 10.1002/glia.20328.View ArticlePubMedGoogle Scholar
- Jack CS, Arbour N, Manusow J, Montgrain V, Blain M, McCrea E, Shapiro A, Antel JP: TLR signaling tailors innate immune responses in human microglia and astrocytes. J Immunol. 2005, 175: 4320-4330.View ArticlePubMedGoogle Scholar
- Kumar H, Kawai T, Akira S: Pathogen recognition by the innate immune system. Int Rev Immunol. 2011, 30: 16-34. 10.3109/08830185.2010.529976.View ArticlePubMedGoogle Scholar
- Zhang SY, Jouanguy E, Ugolini S, Smahi A, Elain G, Romero P, Segal D, Sancho-Shimizu V, Lorenzo L, Puel A, Picard C, Chapgier A, Plancoulaine S, Titeux M, Cognet C, von Bernuth H, Ku CL, Casrouge A, Zhang XX, Barreiro L, Leonard J, Hamilton C, Lebon P, Héron B, Vallée L, Quintana-Murci L, Hovnanian A, Rozenberg F, Vivier E, Geissmann F, Tardieu M, Abel L, Casanova JL: TLR3 deficiency in patients with herpes simplex encephalitis. Science. 2007, 317: 1522-1527. 10.1126/science.1139522.View ArticlePubMedGoogle Scholar
- Wilkins C, Gale M: Recognition of viruses by cytoplasmic sensors. Curr Opin Immunol. 2010, 22: 41-47. 10.1016/j.coi.2009.12.003.PubMed CentralView ArticlePubMedGoogle Scholar
- Ablasser A, Bauernfeind F, Hartmann G, Latz E, Fitzgerald KA, Hornung V: RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat Immunol. 2009, 10: 1065-1072. 10.1038/ni.1779.View ArticlePubMedGoogle Scholar
- Melchjorsen J, Rintahaka J, Søby S, Horan KA, Poltajainen A, Østergaard L, Paludan SR, Matikainen S: Early innate recognition of herpes simplex virus in human primary macrophages is mediated via the MDA5/MAVS-dependent and MDA5/MAVS/RNA polymerase III-independent pathways. J Virol. 2010, 84: 11350-11358. 10.1128/JVI.01106-10.PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.